Related Experiment Video
Updated: Jul 4, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
The future of radiation oncology: the evolution, diversification, and survival of the specialty
1Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. azietman@partners.org
Abstract:
Radiation oncology is a field of medicine that has traveled far over the last century. It has a rich tradition of clinical care and evidence-based practice but in recent years has become increasingly absorbed with technological advances. This increasing emphasis on technology together with other important changes in the health-care economic environment now place the specialty of radiation oncology in a precarious position. If radiation oncologists become simply the guardians of a single therapeutic modality they may find that time marches by and, while the techniques will live on, the specialty may not. This article discusses these threats to the field and examines strategies by which we may evolve, diversify, and thrive.
Related Concept Videos
Radiation: Applications
The average...
Cancer Survival Analysis
Biological Effects of Radiation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers

